Abbott Can't Escape Infringement Claims Over HIV Testing

By Celeste Bott (December 2, 2020, 9:08 PM EST) -- Abbott Laboratories must face allegations that its HIV testing products infringe a patent covering a method for replicating HIV-specific DNA, an Illinois federal judge ruled Tuesday, finding Abbott failed to show the claim was ineligible as a natural phenomenon....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!